Nebraska Cancer Specialists — Omaha, Nebraska

Nebraska Cancer Specialists is a clinical research site located in Omaha, Nebraska, United States 68130.

Crixeo Clinical Trials Trust Score: 31/100 (FAILING). This profile has not yet been claimed by the site owner.

Nebraska Cancer Specialists has participated in 124 clinical trials with 61 currently active.

Therapeutic areas: Triple Negative Breast Cancer, PD-L1 Positive, Hodgkin Disease.

Sponsors: Gilead Sciences, Seagen Inc., Pathos AI, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Omaha

Browse all research sites in Nebraska · View every site in Omaha

Sponsor Feasibility Report

Trust Score: 31/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nebraska Cancer Specialists?

Nebraska Cancer Specialists has a Crixeo Trust Score of 31/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nebraska Cancer Specialists conducted?

Nebraska Cancer Specialists has 124 clinical trials on record, with 61 currently active. Their work covers Triple Negative Breast Cancer, PD-L1 Positive, Hodgkin Disease.

Is Nebraska Cancer Specialists accredited by Crixeo Clinical Trials?

Nebraska Cancer Specialists has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nebraska Cancer Specialists?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.